Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety Evaluation of Inhaleen Inhalation in Hospitalized COVID-19 Patients

NCT04793984 is registered in ClinicalTrials.gov with Marinomed Biotech AG as lead sponsor.

NCT NCT04793984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04793984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety Evaluation of Inhaleen Inhalation in Hospitalized COVID-19 Patients
Lead sponsor
Marinomed Biotech AG
Phase
Not applicable
Overall status
Completed
Start date
March 8, 2021
Completion date
July 30, 2022
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19